Category: Joint ventures/collaborations
-
MD Anderson, Drug Maker Partner on Lung, GI Cancers
MD Anderson Cancer Center and drug maker Boehringer Ingelheim agreed to jointly develop new treatments for lung and gastrointestinal cancers.
-
Darpa Funds Early Disease Detection System
The Defense Department’s advanced research agency is underwriting a system that gives an earlier notice of disease outbreaks and pandemics than current methods.
-
A.I. Finding Cancer Treatments in Generic Drugs
An organization seeking cancer treatments in off-patent generic drugs is partnering with a life science analytics company using artificial intelligence for drug discovery.
-
Industry-Academic Team Studies Myelin Renewal
Researchers are studying techniques for blocking proteins that damage myelin, the protective coating on nerve cells, as occurs in multiple sclerosis and other diseases.
-
Smart Watch, A.I. Analyzing Human Emotions
A study is underway mapping human emotions with data collected by smart watches and analyzed with an app powered by artificial intelligence.
-
Genentech, Biotech Partner on Multiple Sclerosis
A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech.
-
Cold-Chain Drug Delivery Tested Via Drone
A group of companies and organizations designed and tested a long-distance drone capable of delivering drugs needing constant cold temperatures.
-
Voice Indicators to Monitor Dementia Progression
A company developing diagnostics for cognitive disorders from changes in speech patterns is partnering on vocal biomarkers to track progression of a form of dementia.
-
Blockchain Added to Clinical Trials Management
A contract research organization, or CRO, specializing in clinical trials is adding blockchain capability for data management, with help from an engineering consulting firm.
-
Stem Cell Start-Up Raises $250M in Venture Funds
A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing.